US says preemie study didn’t fully disclose risks

Published



WASHINGTON (AP) — Federal health officials say the parents of premature babies enrolled in a study of oxygen treatment several years ago weren’t properly informed of the risks: a kind of blindness or death.

Oxygen has been a mainstay of treatment for very premature babies. But too much has long been known to cause a kind of blindness called retinopathy of prematurity, and too little can increase risk of death. The study in question enrolled 1,300 babies at 23 hospitals between 2005 and 2009, to hunt the best dose somewhere in between.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.